:max_bytes(150000):strip_icc()/GettyImages-2161043945-28b9500cbfd74af4a3f3439f34875dec.jpg?w=1920&resize=1920,1363&ssl=1 "Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio | Global News Avenue")
Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2161043945-28b9500cbfd74af4a3f3439f34875dec.jpg)
Weight loss drugs are transforming medical care and Wall Street, such as Eli Lilly & CO. Leading manufacturer (Liberal) And Novo Nordisk A/S (Non -governmental organization) Seeing the stock price soaring. These drugs are reshaping a medical market for 40 % of obesity adults in the United States. However, for investors, the challenge must not only determine the trend, but also find companies that have not been overestimated.
Key points
- More than 1 billion people in the world suffer from obesity, and these prescription drugs can be treated with these prescription drugs.
- You can invest in weight loss pills by purchasing stocks involved in production companies or investing in assets that hold assets across the industry.
- In order to find value in the hype department, investors can also consider not obvious beneficiaries flying under the radar.
How to invest in diet pills
The most obvious way to invest in this widespread trend is to purchase stocks of companies that produce these drugs or invest in providing open funds to the entire industry.
stock
The cutting -edge of the weight loss pill is Eli Lilly, an American manufacturer of the United States and Zepbough; and Denmark manufacturers of Novo Nordisk, Ozempic, Saxenda and Wegovy. However, they are not the only company in this field. other American Food and Drug Administration-The approved weight loss drug manufacturers include Japanese Takeda Martial Arts, which is headquartered in Boston’s rhythm pharmaceutical company (rhythm) And California’s vivus.
Another option is developers of obesity drugs that have not been released, such as amgen Inc. (Amgn), Viking Treatment Company (VKTX) And structural therapy company (GPCR), Or the establishment of a pharmaceutical giant chase, such as Pfizer Inc.PFE) And Astrazeneca PLC (AZNTo.
Weight loss pills are not only pointing to possible inventory income. Many investors are worried that the major changes in American food habits may affect the stocks and companies such as Walmart Inc. (Walmart Inc.) (WMT) Sell their products.
Trading Trade Fund (ETF)
If you want to invest in the industry as a whole, and diversification In these companies, lose weight ETF It is worth considering.
Recently, some people have been launched to use the trend of weight loss drugs, including enlarged weight loss drugs and treatment ETF (THNR), Roundhill GLP-1 and weight loss ETF (Ozm), And TEMA obesity and heart metabolism ETF (HrtsTo.
How does weight loss pill affect health care inventory?
The issue of investing in the next big event is that its potential will not be kept secret for a long time, and investors will often be excessively stimulated.
As of the end of January 2025, Eli Lilly’s stock rose by about 476 % in five years, and its transaction price was 88 times the company’s company’s revenue in the past 12 months. Novo Nordisk is also very popular: its stock rose 178 % at the same time, and now trades at 28 times the income.
Investors usually need to look at the value of the hype departments farther. This may mean unlikely to investigate suppliers of key materials or determine more people who take weight loss pills.
In addition, parking your funds in mature pharmaceutical companies may pay the price. Sometimes, despite the adaptation and overwhelming competitors, they are still ignored. If this industry meets its commitment, history indicates Pharmaceutical giant May benefit.
Bottom line
The exciting prospect does not necessarily make the company a good investment. During the trend of weight loss drugs, this means that the stock price of these companies may have considered growth potential.
In this case, excessive occupation is also common. A strategy may be the return of companies that are affected by these drugs.
:max_bytes(150000):strip_icc()/GettyImages-2161043945-28b9500cbfd74af4a3f3439f34875dec.jpg?w=1200&resize=1200,0&ssl=1&description=Why+Weight-Loss+Drugs+Could+Be+Game-Changers+for+Your+Investment+Portfolio+%7C+Global+News+Avenue){kind=link}